PGHH 62nd AGM: All 6 Resolutions Passed Unanimously
PGHH's 62nd AGM on September 8, 2026, saw all six resolutions passed. Key decisions included adopting financial statements, declaring dividends, re-appointing Mr. Pramod Agarwal, and appointing Ms. Srividya Srinivasan as Whole-time Director. Voting results confirmed strong shareholder support across all resolutions.
This is a routine annual general meeting where voting results are presented. While important for governance, it does not introduce new material financial information or strategic shifts that would significantly impact the company's market standing in the short term.
The announcement details the successful passing of all resolutions at the company's AGM with overwhelming shareholder support, indicating positive corporate governance and operational alignment.
Procter & Gamble Hygiene and Health Care Limited (PGHH) held its 62nd Annual General Meeting (AGM) on September 8, 2026, at 11:00 a.m. through Video Conferencing (VC) / Other Audio Visual Means (OAVM). All six resolutions presented at the meeting were passed with overwhelming support from shareholders.
The resolutions included the adoption of the Audited Balance Sheet and Profit & Loss statement for the Financial Year ended March 31, 2026, confirmation of interim dividend and declaration of final dividend for the same period, re-appointment of Mr. Pramod Agarwal as a Director, appointment of Ms. Srividya Srinivasan as a Whole-time Director, ratification of remuneration for the Cost Auditor for FY 2026-27, and approval of a Material Related Party Transaction for the purchase of goods.
The voting results, which included remote e-voting and electronic voting during the AGM, showed strong approval for all resolutions. A total of 27,857,198 equity shares were polled for Resolution 1, with 99.9970% in favor. For Resolution 2 regarding dividends, 27,856,353 shares were polled in favor. Resolution 3, concerning the re-appointment of Mr. Pramod Agarwal, saw 27,842,091 shares in favor, and Resolution 4, appointing Ms. Srividya Srinivasan, had 27,607,171 shares in favor. Resolution 5, ratifying the Cost Auditor's remuneration, received 27,856,334 shares in favor, and Resolution 6, the related party transaction, had 49,26,560 shares in favor.
The meeting was conducted in compliance with circulars from the Ministry of Corporate Affairs and SEBI. Mr. Kamalax G Saraf from M K Saraf & Associates LLP served as the Scrutinizer for the e-voting process.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.